author-photo

Katharine Cuff

Princess Alexandra Hospital

16

Papers

72

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

RTID-05. THE MULTI-ARM GLIOBLASTOMA AUSTRALASIA (MAGMA) TRIAL

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Australian real-world outcomes of ribociclib and aromatase inhibitor in hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC): Results from Kisqali Access Registry for Metastatic breast cancer in Australia (KARMA) collected alongside a medicine access program.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Changing from telephone to videoconference for pre-treatment pharmacist consults in cancer services: Impacts to funding and time efficiency:

2021 Journal of Telemedicine and Telecare
Show All
- Source
- Cite
- Save
Citations (0)
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol.

2021 Contemporary clinical trials communications
Show All
- Source
- Cite
- Save
Citations (0)
Safety and unique pharmacokinetic profile of ARX788, a site-specific ADC, in heavily pretreated patients with HER2-overexpresing solid tumors: Results from two phase 1 clinical trials.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
Phase II trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-), locally advanced or metastatic breast cancer (BC) with prior exposure to hormonal therapies.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Intratumoral IL-12 plus pembrolizumab combination therapy in treatment refractory solid tumors: a safety and biomarker analysis

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in patients with advanced renal cell carcinoma (RCC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)